Sirolimus-Eluting Coronary Stents [1] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 4, 2004, Pages 413-414

  Mack, Michael J ^a   Drenth, Derk J ^b   Zijlstra, Felix ^b   Boonstra, Piet W ^b   Moses, Jeffrey W ^c   Leon, Martin B ^c  

^a MEDICAL CITY DALLAS HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT;

ANGIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; HEALTH CARE COST; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK ASSESSMENT; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; ECONOMICS; NOTE; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; ANGIOCARDIOGRAPHY; CLASSIFICATION; CORONARY ARTERY BYPASS GRAFT; PATHOLOGY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; STENTS; TREATMENT FAILURE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS;

EID: 0345872077     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200401223500418     Document Type: Letter

References (0)